Companies / RayzeBio, Inc.
RayzeBio, Inc.
RYZBCIK 1825367
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Song Kenneth CEO | Other Sold to issuer | Common Stock | $101.44M | -1.6M -100.00% | 0 | low |
| Feb 26, 2024 | Katabi Maha Director | Other Sold to issuer | Common Stock | $75.61M | -1.2M -100.00% | 0 | low |
| Feb 26, 2024 | Katabi Maha Director | Other Sold to issuer | Common Stock | $75.61M | -1.2M -100.00% | 0 | low |
| Feb 26, 2024 | Heyman Richard A. Director | Other Sold to issuer | Common Stock | $22.97M | -367K -100.00% | 0 | low |
| Feb 26, 2024 | Moran Susan Executive | Other Sold to issuer | Common Stock | $20.22M | -323K -100.00% | 0 | low |
| Sep 19, 2023 | Viking Global Investors LP 10% owner | Buy Open-market buy | Common Stock | $16.75M | +931K +23.45% | 4,899,144 | high |
| Sep 19, 2023 | Viking Global Investors LP 10% owner | Buy Open-market buy | Common Stock | $16.75M | +931K +23.45% | 4,899,144 | high |
| Sep 19, 2023 | Viking Global Investors LP 10% owner | Buy Open-market buy | Common Stock | $8.25M | +458K +35.66% | 1,743,556 | high |